BATS BZX Real-Time Price
As of 11:18am ET
| +0.61 / +9.55%|
The 4 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 25.00, with a high estimate of 28.00 and a low estimate of 17.50. The median estimate represents a +257.14% increase from the last price of 7.00.
The current consensus among 4 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.